Project Grant R01MH143902
- Federal Project Grant Award Summary The National Institute of Mental Health (NIMH) awarded the University of Southern California a $817,597 Project Grant (CFDA 93.242 – Mental Health Research Grants) on September 19, 2025, to develop machine learning prediction models for identifying autistic children and youth at greatest risk for persistent adverse mental health outcomes. The primary deliverables include: (1) identification and extraction of social determinants of health (SDOH) factors from...
- Federal Project Grant Award Summary The National Institute of Mental Health (NIMH) awarded Massachusetts General Hospital a Project Grant totaling $129,290 on August 22, 2025, under the Mental Health Research Grants program (CFDA 93.242). This research project, extending through July 31, 2027, focuses on mapping genotype to developmental course across an autism spectrum disorder (ASD) and schizophrenia (SCZ) gradient. The Principal Investigator will analyze phenotypic, genetic, and...
- Federal Project Grant Award Summary The National Institute of Mental Health (NIMH) awarded Massachusetts General Hospital a $824,728 Project Grant on March 25, 2026, under the Mental Health Research Grants program (CFDA 93.242) to support basic neuroscience research investigating the neurobiological mechanisms underlying Autism Spectrum Disorder (ASD). The grant funds a multimodal neuroimaging study that will characterize feedforward and feedback sensory processing along the auditory cortical...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded Children's Hospital Los Angeles a $769,500 Project Grant under the Mental Health Research Grants program (CFDA 93.242) for a three-year research initiative running from March 15, 2026 through March 14, 2029. The grant supports the feasibility, acceptability, and preliminary effectiveness evaluation of Cognitive Behavioral Therapy for Depression in Autistic Youth (CBT-DAY) when delivered by clinicians with...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded Stanford University $767,029 on July 6, 2026, under the Mental Health Research Grants program (CFDA 93.242) to develop and validate a multimodal assessment protocol for characterizing restricted and repetitive behaviors (RRB) in autism spectrum disorder (ASD). The project will produce three primary deliverables: (1) a computerized adaptive test version of the Dimensional Assessment of Restricted and Repetitive...
- Award Summary The National Institute of Mental Health (NIMH) awarded $762,566 to the University of Maryland, Baltimore on April 1, 2026, under the Mental Health Research Grants program (CFDA 93.242) to conduct a comprehensive multi-omic and synaptic imaging study quantifying cerebellar features associated with autism spectrum disorders (ASDs). The research will generate single-nuclei multi-omic profiles of gene expression and chromatin accessibility from approximately 1.5 million cells derived...
- Federal Project Grant Award Summary The National Institute of Mental Health (NIMH) awarded Boston Children's Hospital a $990,550 Project Grant (CFDA 93.242, Mental Health Research Grants) effective March 10, 2026, through February 29, 2028, to develop and test a novel cognitive control and metacognition training intervention for school-aged children with autism spectrum disorder (ASD). The research delivers an in-person, computer-based cognitive control training program combined with...
- Federal Project Grant Award Summary The National Institute of Mental Health (NIMH) awarded a $123,498 Project Grant (CFDA 93.242: Mental Health Research Grants) to the University of California, Davis on June 5, 2026, with completion scheduled for May 31, 2028. This award supports research addressing a critical inflection point in autism intervention science—specifically investigating the quality, safety, and acceptability of early intervention (EI) services in light of concerns raised by the...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded $442,750 to the University of California, Davis under the Mental Health Research Grants program (CFDA 93.242) for the project period April 1, 2026 through March 31, 2028. The award funds the development of novel statistical methodologies for predicting individualized intervention effects in clustered and longitudinal datasets. The primary deliverables include the creation of innovative statistical frameworks...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded UCLA a $1.92M Project Grant on September 18, 2025, under the Mental Health Research Grants program (CFDA 93.242) to conduct the Coaching and Leadership in Autism Support Settings (CLASS) study through August 31, 2030. This cluster-randomized, hybrid effectiveness-implementation trial will evaluate the clinical effectiveness of the Research Units on Behavioral Interventions in Educational Settings (RUBIES)...
The National Institute of Mental Health (NIMH) awarded the University of Southern California a Project Grant of $855,772 under the Mental Health Research Grants program (CFDA 93.242) on July 15, 2026, with a completion date of April 30, 2031. This research initiative aims to characterize autism spectrum disorder (ASD) heterogeneity through machine learning methods while identifying underlying genetic and environmental drivers. The project will utilize an unsupervised machine learning approach called Discriminative Dimensionality Reduction Tree (DDRTREE) to construct clinically relevant ASD subtypes and severity scores based on core symptom presentation and co-occurring conditions, addressing current limitations in diagnosis and treatment planning that result from substantial clinical heterogeneity in the ASD population. The research will expand upon preliminary findings from the Simons Foundation Powering Autism Research for Knowledge (SPARK) initiative by analyzing approximately 55,000 autistic individuals across multiple cohorts to link identified ASD subtypes and severity variations to specific genetic and prenatal risk factors. In Aim 1, researchers will construct and validate machine learning-derived ASD subtypes and severity scores using symptom and comorbidity data from approximately 45,000 individuals in SPARK, with external validation in approximately 10,000 additional participants. The deliverables will include dimensional ASD subtype classification systems that better reflect real-world support needs and differential patterns of intervention use, advancing understanding of ASD etiology and potentially enabling more precise intervention and treatment planning strategies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $855.8k | 7/17/26 |